On October 2, JD HEALTH fell 4.83% in regular trading, trading at 34.34 HKD/share, with turnover of approximately 49.71 million HKD. The decline came amid broad-based weakness across Hong Kong-listed technology stocks at the open.

On the macro front, rising US Treasury yields continued to weigh on global risk assets, with the 10-year US Treasury yield recently touching 5.29%. The Hang Seng Index opened 513 points lower, falling 2.09%, while the Hang Seng Tech Index dropped 1.81% at the open. Market participants noted that the mainland China holiday period further dampened capital activity, leaving indices without near-term upside momentum. Analysts expect the Hang Seng Index to remain range-bound between 24,000 and 25,000 points in the short term.

Within the Internet and Direct Marketing Retail sector, declines were widespread. JD-SW fell 2.97%, PA GOODDOCTOR fell 4.02%, BABA-W fell 2.25%, MEITUAN-W fell 2.02%, and ALI HEALTH fell 1.05%. As a Hang Seng Tech Index constituent, JD HEALTH was notably impacted by the systematic sector pullback. September saw the Hang Seng Tech Index decline nearly 8% for the month, underscoring persistent pressure from elevated global interest rates on Hong Kong-listed growth stocks.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)